Lenvima

ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype
Fierce Pharma
Sun, 09/15/24 - 06:30 pm
ESMO
Merck
Eisai
Keytruda
Lenvima
liver cancer
ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer
Fierce Pharma
Tue, 06/4/24 - 11:52 am
ASCO 2024
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Merck
Eisai
Bayer
Lenvima
Nexavar
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
Merck and Eisai tease results for renal carcinoma treatment
Clinical Trials Arena
Tue, 05/30/23 - 09:18 pm
Merck
Eisai
ASCO 2023
Lenvima
Keytruda
renal cell carcinoma
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Fri, 04/7/23 - 01:58 pm
Merck
Keytruda
Eisai
Lenvima
melanoma
clinical trials
cancer
colorectal cancer
Medivir completes initial Phase Ib part of HCC therapy trial
Clinical Trials Arena
Tue, 02/21/23 - 10:05 am
Medvir
fostrox
Lenvima
hepatocellular carcinoma
clinical trials
Merck's Keytruda, on a losing streak, fails in once FDA-rejected liver cancer use and prostate cancer—again
Fierce Pharma
Wed, 08/3/22 - 09:15 pm
Merck
Keytruda
FDA
liver cancer
Lenvima
ASCO: Merck's Keytruda combo data could spark hope for lymphoma patients who lack options
Fierce Biotech
Fri, 05/27/22 - 10:17 am
ASCO 2022
Merck
Keytuda
Lynparza
Lenvima
Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer
Endpoints
Thu, 07/22/21 - 10:14 pm
Merck
Keytruda
Lenvima
endometrial cancer
FDA
Merck breathes a sigh of relief as Keytruda-Lenvima combo aces confirmatory study in endometrial cancer
Endpoints
Fri, 03/19/21 - 10:51 am
Merck
FDA
Keytruda
Eisai
Lenvima
clinical trials
endometrial cancer
Merck's Keytruda Plus Eisai's Lenvima Could Open New Standard of Care in Renal Cancer
BioSpace
Tue, 02/16/21 - 11:12 am
Merck
ASCO GU
Keytruda
Eisai
Lenvima
renal cell carcinoma
Could Keytruda/Lenvima Combo Help Treat Advanced Renal Cell Carcinoma?
BioSpace
Tue, 11/10/20 - 11:10 am
Merck
Eisai
Keytruda
Lenvima
clinical trials
advanced renal cell carcinoma
ESMO: Where will Merck, Eisai take Keytruda-Lenvima next? Ovarian and colorectal cancer could be good options, data show
Fierce Pharma
Sun, 09/20/20 - 07:44 pm
Merck
Eisai
Keytruda
Lenvima
ovarian cancer
colorectal cancer
FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
Endpoints
Wed, 07/8/20 - 10:43 am
Merck
FDA
complete response letter
Keytruda
Eisaid
Lenvima
hepatocellular carcinoma
Roche
ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data
Fierce Pharma
Mon, 06/1/20 - 12:00 am
Merck
Eisai
liver cancer
ASCO 2020
Keytrua
Lenvima
clinical trials
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Sun, 09/29/19 - 09:37 pm
Merck
Eisai
Keytruda
Lenvima
endometrial cancer
ESMO
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Fierce Pharma
Wed, 09/18/19 - 09:56 am
Merck
Keytruda
Eisai
Lenvima
endometrial cancer
Canada
Australia
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
Wed, 09/5/18 - 10:15 am
China
Eisai
Merck
Lenvima
liver cancer
HCC

Pages